Skip to main content
editorial
. 2022 Jan;11(1):100–110. doi: 10.21037/tlcr-21-1039

Figure 3.

Figure 3

Identification and validation of the latent transforming growth factor beta-binding protein 1 (LTBP1)-anaplastic lymphoma kinase (ALK) fusion in a NSCLC patient. (A) DNA sequencing reads of LTBP1 and ALK were visualized by the Integrative Genomics Viewer (IGV); (B) a schematic map showing the structure of the LTBP1-ALK fusion locus. NSCLC, non-small cell lung cancer.